Stay updated on Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page’s site revision label was updated from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check8 days agoChange DetectedThe 403 screen is replaced by the ClinicalTrials.gov record for the completed Measure Up 2 study, with its study details, outcomes, publications, and data-sharing information.SummaryDifference100%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check29 days agoChange DetectedA sitewide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology during a period of transition.SummaryDifference1%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1, while the study record remains unavailable with a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.